Deborah Birx
Chief Executive Officer chez ARMATA PHARMACEUTICALS, INC.
Fortune : 2 M $ au 31/03/2024
Profil
Deborah L.
Birx is currently the Chief Executive Officer & Director at Armata Pharmaceuticals, Inc. and a Director at Nanolive SA. Previously, she served as an Independent Director at Innoviva, Inc. from 2021 to 2023.
Dr. Birx completed her undergraduate degree at Houghton College in 1976 and obtained her doctorate from Pennsylvania State University College of Medicine in 1980.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 14/03/2024 | 260 000 ( 0,72% ) | 1 M $ | 31/03/2024 | |
INNOVIVA, INC.
0,09% | 22/05/2023 | 58 984 ( 0,09% ) | 898 916 $ | 31/03/2024 |
Postes actifs de Deborah Birx
| Sociétés | Poste | Début |
|---|---|---|
| ARMATA PHARMACEUTICALS, INC. | Chief Executive Officer | 11/07/2023 |
Nanolive SA
 Nanolive SA Medical SpecialtiesHealth Technology Nanolive SA develops revolutionary tomographic microscope to look instantly inside living cells in 3D. Its device scans cell division, cell organelles and cell morphology, cell differentiation, cell-cell interaction, intracellular trafficking, cellular remodeling processes, drug monitoring, and in vitro fertilization. The company was founded in November 2013 by Yann Cotte, Sebastien Equis, and Andreas Kern, Fatih Toy, Christian Depeursinge and is headquartered in Ecublens, Switzerland. | Director/Board Member | - |
Anciens postes connus de Deborah Birx
| Sociétés | Poste | Fin |
|---|---|---|
| INNOVIVA, INC. | Director/Board Member | 10/07/2023 |
Formation de Deborah Birx
| Houghton College | Undergraduate Degree |
| Pennsylvania State University College of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| INNOVIVA, INC. | Health Technology |
| ARMATA PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Nanolive SA
Nanolive SA Medical SpecialtiesHealth Technology Nanolive SA develops revolutionary tomographic microscope to look instantly inside living cells in 3D. Its device scans cell division, cell organelles and cell morphology, cell differentiation, cell-cell interaction, intracellular trafficking, cellular remodeling processes, drug monitoring, and in vitro fertilization. The company was founded in November 2013 by Yann Cotte, Sebastien Equis, and Andreas Kern, Fatih Toy, Christian Depeursinge and is headquartered in Ecublens, Switzerland. | Health Technology |
